DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) had its target price lowered by equities researchers at Needham & Company LLC from $34.00 to $29.00 in a note issued to investors on Friday, MarketBeat.com reports. The brokerage currently has a "buy" rating on the medical instruments supplier's stock. Needham & Company LLC's price target suggests a potential upside of 24.41% from the company's previous close.
Several other equities research analysts also recently issued reports on the stock. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a research note on Thursday, July 18th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 8th. Barrington Research reiterated an "outperform" rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Finally, Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating on the stock in a report on Monday, July 22nd. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Moderate Buy" and a consensus target price of $32.67.
Check Out Our Latest Analysis on XRAY
DENTSPLY SIRONA Stock Down 4.5 %
Shares of NASDAQ:XRAY traded down $1.10 during trading on Friday, hitting $23.31. 3,643,837 shares of the company were exchanged, compared to its average volume of 2,965,525. DENTSPLY SIRONA has a fifty-two week low of $22.85 and a fifty-two week high of $37.60. The stock has a market cap of $4.73 billion, a price-to-earnings ratio of -27.13, a P/E/G ratio of 1.17 and a beta of 1.00. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The firm has a fifty day moving average price of $25.26 and a two-hundred day moving average price of $26.58.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. During the same period in the prior year, the business posted $0.51 earnings per share. DENTSPLY SIRONA's quarterly revenue was down 4.3% compared to the same quarter last year. As a group, research analysts anticipate that DENTSPLY SIRONA will post 1.98 earnings per share for the current fiscal year.
Hedge Funds Weigh In On DENTSPLY SIRONA
Several institutional investors and hedge funds have recently modified their holdings of XRAY. State of Alaska Department of Revenue boosted its holdings in DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier's stock valued at $637,000 after purchasing an additional 560 shares during the period. Wealth Enhancement Advisory Services LLC boosted its stake in shares of DENTSPLY SIRONA by 43.9% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,038 shares of the medical instruments supplier's stock valued at $326,000 after buying an additional 3,671 shares during the period. Osborne Partners Capital Management LLC grew its position in DENTSPLY SIRONA by 1.1% during the third quarter. Osborne Partners Capital Management LLC now owns 332,423 shares of the medical instruments supplier's stock worth $8,995,000 after buying an additional 3,556 shares in the last quarter. Allworth Financial LP grew its holdings in shares of DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock worth $59,000 after purchasing an additional 625 shares in the last quarter. Finally, Country Club Bank bought a new position in DENTSPLY SIRONA in the 3rd quarter valued at about $4,084,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
